What are the Challenges Associated with Active Metabolites?
While active metabolites can enhance the efficacy of cancer drugs, they also pose challenges. One of the primary challenges is interindividual variability in metabolism, which can lead to differences in drug response and toxicity among patients. Genetic polymorphisms in CYP450 enzymes can significantly affect the formation and clearance of active metabolites, necessitating personalized approaches to cancer treatment.